- Report
- October 2020
- 18 Pages
Australia
From €2845EUR$2,995USD£2,440GBP
From €7125EUR$7,500USD£6,110GBP
- Report
- December 2019
- 218 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- January 2019
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- January 2019
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- December 2018
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- October 2021
- 150 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- October 2021
- 58 Pages
Global
From €2375EUR$2,500USD£2,037GBP
- Report
- October 2021
- 101 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- October 2021
- 91 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- April 2021
- 145 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- April 2021
- 40 Pages
Global
From €2375EUR$2,500USD£2,037GBP
- Report
- March 2021
- 91 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Report
- January 2022
- 130 Pages
United States
From €4750EUR$5,000USD£4,073GBP
- Report
- January 2022
- 158 Pages
China
From €4750EUR$5,000USD£4,073GBP
From €3325EUR$3,500USD£2,851GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- June 2023
- 113 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- November 2020
- 41 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €3795EUR$3,995USD£3,254GBP
- Report
- October 2020
- 19 Pages
Italy
From €2845EUR$2,995USD£2,440GBP
The Percutaneous Coronary Intervention (PCI) Device market is a segment of the Cardiovascular Devices market. It includes devices used to treat coronary artery disease, such as balloon catheters, stents, guidewires, and other accessories. These devices are used to open blocked arteries, restore blood flow, and reduce the risk of heart attack. PCI devices are minimally invasive, allowing for faster recovery times and fewer complications than traditional open-heart surgery.
The PCI Device market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. The market is further supported by government initiatives to reduce the burden of cardiovascular diseases and the increasing availability of healthcare services.
Some of the major companies in the PCI Device market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, B. Braun Melsungen AG, Terumo Corporation, and Edwards Lifesciences Corporation. Show Less Read more